Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells

doi:10.3748/wjg.v13.i13.1947

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 13

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2487)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

308

HTML

1788

Figures (1-5)

257

Tables (1-1)

134

Sum=2487

Apr 7, 2007 (publication date) through Jul 27, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Apr 7, 2007; 13(13): 1947-1952
Published online Apr 7, 2007. doi: 10.3748/wjg.v13.i13.1947

Full Size Figure Download Figure

Figure 1 Viability of colon cancer cells treated with 5-FU and celecoxib. Cell viability was determined by MTT assay. Cell viabilities at various concentrations of 5-FU (A) and celecoxib (B) were evaluated using a cell viability index (%), which was defined as: (mean absorbance in the test group/mean absorbance in the control group) x 100. Black bars represent HCT-15 cells and white bars HT-29 cells. Results are mean ± SE.

Citation: Lim YJ, Rhee JC, Bae YM, Chun WJ. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells. World J Gastroenterol 2007; 13(13): 1947-1952
URL: https://www.wjgnet.com/1007-9327/full/v13/i13/1947.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i13.1947